Updated July 2026 · 8 min read
Part of the ICU Emergencies Hub — browse every related guide in one place.
Beta-blocker and calcium-channel-blocker overdoses sit together because they do the same terrible thing from two directions: they drop the heart rate and the blood pressure until the patient is in cardiogenic shock, and they can be stubbornly resistant to the usual pressors. What makes them fascinating — and survivable — is that the most effective treatments are deeply counterintuitive: a massive insulin infusion given with sugar, and high doses of calcium. The nurse who is comfortable running high-dose insulin euglycemic therapy is running one of the true lifesaving ICU protocols.
Both classes suppress the heart, but by different levers. Beta-blockers blunt the sympathetic (beta-receptor) drive, slowing the rate and weakening contractility. Calcium-channel blockers block the calcium influx the heart and vessels need — the non-dihydropyridines (verapamil, diltiazem) hit the heart's rate and contractility hard, while the dihydropyridines (amlodipine) act more on the blood vessels and cause profound vasodilation. The end result overlaps: a slow heart, a failing pump, and low vascular tone. One useful bedside discriminator is the glucose: CCBs block pancreatic insulin release and typically produce hyperglycemia, whereas beta-blocker patients usually have normal or low glucose.
| Feature | Beta-blocker | Calcium-channel blocker |
|---|---|---|
| Core mechanism | Blocks beta-adrenergic drive | Blocks calcium influx into heart/vessels |
| Heart rate / pump | Bradycardia, reduced contractility | Bradycardia (verapamil/diltiazem), vasodilation (amlodipine) |
| Blood glucose | Normal or low | Often high (blocks insulin release) |
| Mental status | Can be depressed (esp. propranolol, CNS effects) | Often preserved until late |
The treatment that surprises people is high-dose insulin euglycemic therapy (HIET): an insulin infusion at doses many times higher than a diabetic drip, run alongside dextrose to keep the blood sugar normal. The poisoned heart shifts to using glucose for fuel, and high-dose insulin acts as an inotrope — improving cardiac contractility — while also helping vascular tone. It works, but it demands disciplined nursing: frequent glucose checks (with dextrose titrated to prevent hypoglycemia) and close potassium monitoring (insulin drives potassium into cells). The effect isn't instant — it takes time to build — so it's started early and not abandoned prematurely.
Treatment is layered and escalated based on response. IV calcium (calcium chloride or gluconate) helps most in CCB toxicity by overcoming the channel blockade. Glucagon is the classic beta-blocker move, raising heart rate and contractility through a pathway that bypasses the beta receptor (expect vomiting — protect the airway). Standard measures — fluids, atropine for bradycardia (often disappointing), and vasopressors such as norepinephrine or epinephrine — run alongside. IV lipid emulsion is reserved for refractory cardiovascular collapse, especially with lipophilic agents. For overdoses of extended-release products, whole-bowel irrigation may be used to clear un-absorbed pills. When everything fails, transvenous pacing or mechanical support like ECMO can bridge the patient until the drug clears.
Extended-release formulations are a special hazard. A patient can present awake with only mild bradycardia, then deteriorate hours later as the sustained-release tablets keep dissolving and delivering drug. That means a reassuring early picture with a large reported ingestion of a sustained-release beta-blocker or CCB still warrants ICU-level monitoring, early decontamination when appropriate, and readiness to start therapy the moment the numbers turn. Continuous cardiac monitoring and serial vitals are how you catch the turn before it becomes a code.
Beta-blocker and calcium-channel-blocker overdoses converge on the same lethal picture — bradycardia, hypotension, and cardiogenic shock — from two mechanisms, with hyperglycemia pointing toward a CCB and preserved or low glucose toward a beta-blocker. The standout treatments are counterintuitive: high-dose insulin euglycemic therapy acts as an inotrope and demands vigilant glucose and potassium management, calcium helps most in CCB toxicity, and glucagon is the classic beta-blocker agent, all layered with fluids and vasopressors and, in refractory collapse, lipid emulsion, pacing, or ECMO. Extended-release products can crash a patient hours after a calm presentation. The nurse's highest-value work is running HIET safely and driving the escalation early, because in these poisonings the difference between recovery and arrest is often how aggressively and how soon the team pushes the unconventional therapies.
Related: TCA overdose · Digoxin · Vasopressor guide · Dextrose & hypoglycemia
Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.